| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |